Dental extraction in congenital factor Vll deficiency with inhibitor – a case report

1 Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood 2019; 133(5): 415–424. doi: 10.1182/blood-2018-06-820738. MenegattiM PeyvandiF Treatment of rare factor deficiencies other than hemophilia Blood 2019 133 5 415 424 10.1182/blood-2018-06-820738 30559262 Open DOISearch in Google Scholar

2 Pikija S, Gampenrieder SP, Millesi K, Pilz, G, Weis, S, Mutzenbach, JS. Factor VII deficiency in major artery occlusion stroke. Am J Hematol 2018; 93: 843–845. doi: 10.1002/ajh.25031. PikijaS GampenriederSP MillesiK PilzG WeisS MutzenbachJS Factor VII deficiency in major artery occlusion stroke Am J Hematol 2018 93 843 845 10.1002/ajh.25031 29318701 Open DOISearch in Google Scholar

3 Kim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC. Surgery in patients with congenital factor VII deficiency: A single center experience. Korean J Hematol 2012; 47(4): 281–285. doi: 10.5045/kjh.2012.47.4.281. KimSH ParkYS KwonKH LeeJH KimKC YooMC Surgery in patients with congenital factor VII deficiency: A single center experience Korean J Hematol 2012 47 4 281 285 10.5045/kjh.2012.47.4.281 353880023320007 Open DOISearch in Google Scholar

4 Mahale R, Rathi P, Ginegiri C, Aggarwal R. Factor VII deficiency: A rare case report. Indian J Hematol Blood Transfus 2010; 26: 68–9. doi: 10.1007/s12288-010-0023-5. MahaleR RathiP GinegiriC AggarwalR Factor VII deficiency: A rare case report Indian J Hematol Blood Transfus 2010 26 68 9 10.1007/s12288-010-0023-5 300206821629640 Open DOISearch in Google Scholar

5 ELShama HA, ELokda SA. Effect of activated recombinant factor VII versus tranexamic acid infusion on bleeding during spine surgery, randomized, controlled, double blinded trial. Egyptian Journal of Anaesthesia 2015; 31(2): 149–153. doi: 10.1016/j.egja.2014.12.009. ELShamaHA ELokdaSA Effect of activated recombinant factor VII versus tranexamic acid infusion on bleeding during spine surgery, randomized, controlled, double blinded trial Egyptian Journal of Anaesthesia 2015 31 2 149 153 10.1016/j.egja.2014.12.009 Open DOISearch in Google Scholar

6 Ingerslev J, Knudsen L, Hvid I, Tange MR, Fredberg U, Sneppen O. Use of recombinant factor VIIa in surgery in factor-VII-deficient patients. Haemophilia 1997; 3(3): 215–218. doi: 10.1046/j.1365-2516.1997.00105.x. IngerslevJ KnudsenL HvidI TangeMR FredbergU SneppenO Use of recombinant factor VIIa in surgery in factor-VII-deficient patients Haemophilia 1997 3 3 215 218 10.1046/j.1365-2516.1997.00105.x 27214810 Open DOISearch in Google Scholar

7 Tokgoz H, Caliskan U, Lavigne-Lissalde G, Giansily-Blaizot M. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII. Haemophilia 2012; 18(1): e25–7. doi: 10.1111/j.1365-2516.2011.02666.x. TokgozH CaliskanU Lavigne-LissaldeG Giansily-BlaizotM Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII Haemophilia 2012 18 1 e25 7 10.1111/j.1365-2516.2011.02666.x 21973016 Open DOISearch in Google Scholar

8 Şenol BK, Zülfikar B. Clinical problems and surgical interventions in inherited factor VII deficiency. Turk Pediatri Ars 2020; 55(2): 184–190. doi: 10.14744/TurkPediatriArs.2020.79069. ŞenolBK ZülfikarB Clinical problems and surgical interventions in inherited factor VII deficiency Turk Pediatri Ars 2020 55 2 184 190 10.14744/TurkPediatriArs.2020.79069 734412732684764 Open DOISearch in Google Scholar

9 Nicolaisen EM. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience. Blood Coagul Fibrinolysis 1998; 9 Suppl 1: S119–23. NicolaisenEM Antigenicity of activated recombinant factor VII followed through nine years of clinical experience Blood Coagul Fibrinolysis 1998 9 Suppl 1 S119 23 Search in Google Scholar

10 Shams M, Dorgalaleh A, Safarian N, et al. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients. Blood Coagul Fibrinolysis 2019; 30(1): 24–28. doi: 10.1097/MBC.0000000000000791. ShamsM DorgalalehA SafarianN Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients Blood Coagul Fibrinolysis 2019 30 1 24 28 10.1097/MBC.0000000000000791 30585836 Open DOISearch in Google Scholar

11 Levitt MJ, Topilow AA, Lerner W, et al. A case of FVII inhibitor. Blood 2010; 116(21): 3655. doi: 10.1182/blood.V116.21.3655.3655. LevittMJ TopilowAA LernerW A case of FVII inhibitor Blood 2010 116 21 3655 10.1182/blood.V116.21.3655.3655 Open DOISearch in Google Scholar

12 Brewer A, Correa ME; World Federation of Hemophilia Dental Committee. Guidelines for dental treatment of patients with inherited bleeding disorders. World Federation of Hemophilia, Treatment of Hemophilia, 2006. Available from https://elearning.wfh.org/resource/guidelines-for-dental-treatment-of-patients-with-inherited-bleeding-disorders/ (accessed 23 April 2021). BrewerA CorreaME World Federation of Hemophilia Dental Committee Guidelines for dental treatment of patients with inherited bleeding disorders World Federation of Hemophilia, Treatment of Hemophilia 2006 Available from https://elearning.wfh.org/resource/guidelines-for-dental-treatment-of-patients-with-inherited-bleeding-disorders/ (accessed 23 April 2021). Search in Google Scholar

13 Weinstock RJ, Onyejiuwa A, Shnayder G, Clarkson EI. Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report. J Am Dent Assoc 2015; 146(4): 271–5. doi: 10.1016/j.adaj.2014.12.022. WeinstockRJ OnyejiuwaA ShnayderG ClarksonEI Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report J Am Dent Assoc 2015 146 4 271 5 10.1016/j.adaj.2014.12.022 25819659 Open DOISearch in Google Scholar

14 Peisker A, Raschke GF, Schultze-Mosgau S. Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions. Med Oral Patol Oral Cir Bucal 2014; 19(1): e55–e60. doi: 10.4317/medoral.19191. PeiskerA RaschkeGF Schultze-MosgauS Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions Med Oral Patol Oral Cir Bucal 2014 19 1 e55 e60 10.4317/medoral.19191 390943324121912 Open DOISearch in Google Scholar

15 Kazancıoğlu HO, Çakıir O, Gülsüm A, Zülfikar B. The effectiveness of a new hemostatic agent (Ankaferd Blood Stopper) for the control of bleeding following tooth extraction in hemophilia: A controlled clinical trial. Turk J Hematol 2013; 30: 19–24. doi: 10.4274/tjh.2012.0036. KazancıoğluHO ÇakıirO GülsümA ZülfikarB The effectiveness of a new hemostatic agent (Ankaferd Blood Stopper) for the control of bleeding following tooth extraction in hemophilia: A controlled clinical trial Turk J Hematol 2013 30 19 24 10.4274/tjh.2012.0036 378166724385748 Open DOISearch in Google Scholar